News & Views

Oncology nursing community

Cancer Care When Disaster Strikes

In the early hours of September 13, 2008, Hurricane Ike—a category 2 hurricane—hit Galveston Island, TX, bringing with it sustained winds of up to 110 miles per hour and storm surges reaching as high as 17 feet. By the next day, more than 200 shelters had opened across Texas to house the estimated 40,000 people who had been forced to evacuate from their homes.

August 30, 2017

Trending Topics

View All Topics

Cancer Care for Patients After a Natural Disaster

Oncology nursing community

How Did You Continue to Provide Cancer Care for Patients After a Natural Disaster?

August 30, 2017

FDA Update

U.S. Food and Drug Administration (FDA)

FDA Approves Tisagenlecleucel for B-cell ALL, Tocilizumab for Cytokine Release Syndrome

August 30, 2017

quality improvement, evidence-based practice and research in oncology

Evidence-based care

The Difference Between Quality Improvement, Evidence-Based Practice, and Research

August 29, 2017

Natural Disasters Take a Toll on Both Patients and Nurses

Oncology nursing community

Natural Disasters Take a Toll on Both Patients and Nurses, at the Cancer Center and at Home

August 29, 2017

Ambulatory Staffing

What Is ONS’s Perspective on the Ambulatory Staffing Dilemma?

August 23, 2017

periodontis

Cancer research

Periodontal Disease May Increase Risk for Non-Hodgkin Lymphoma

August 23, 2017

access device standards

Evidence-Based Standards Guide the Use and Maintenance of Venous Implanted Ports

August 22, 2017

Reframe Workplace Conflicts

Incivility in nursing

Reframe Workplace Conflicts

August 21, 2017

fda update

U.S. Food and Drug Administration (FDA)

FDA Approves Olaparib Tablets for Maintenance Treatment in Ovarian Cancer

August 17, 2017

fda update

U.S. Food and Drug Administration (FDA)

FDA Approves Inotuzumab Ozogamicin for Relapsed, Refractory B-Cell Precursor ALL

August 17, 2017

Addressing Hypersensitivity Reactions to Chemotherapy

Time Is Short When Addressing Hypersensitivity Reactions to Chemotherapy

August 17, 2017

Herbs and cancer drugs

Clinical practice

Are Your Patients Taking Herbs That May Interact With Their Cancer Drugs?

August 15, 2017

Cancer treatment and anxiety

Psychosocial issues

The Case of the Anxiety Answer

August 15, 2017

Patients Randomized to Cancer Clinical Trials

National Cancer Institute (NCI)

How Are Patients Randomized to Cancer Clinical Trials?

August 10, 2017

Brenda Nevidjon

Becoming a Healthy You Contributes to a Healthy Nation

August 10, 2017

inferior palliative care for minority oncology patients

End of life (EOL)

Ethnic Minority Patients May Receive Inferior End-of-Life Care

August 09, 2017

Scalp Cooling for Chemotherapy-Induced Alopecia

Treatment side effects

How Safe and Effective Is Scalp Cooling for Chemotherapy-Induced Alopecia?

August 08, 2017

FDA Update

U.S. Food and Drug Administration (FDA)

FDA Approves Liposome-Encapsulated Combination of Daunorubicin-Cytarabine for Patients With AML

August 03, 2017

hematopoietic stem cell transplant care

Advanced practice nursing (APN)

Safely Provide Outpatient Care to Patients Receiving Hematopoietic Stem Cell Transplantations

August 03, 2017

FDA Update

U.S. Food and Drug Administration (FDA)

FDA Expands Ibrutinib Indications to Chronic GVHD

August 02, 2017

Board of Directors Sets Goals for 2017–2018

August 02, 2017

increase in incidence of lung adenocarcinoma

“Light” Cigarettes to Blame for Rise in Lung Adenocarcinoma

August 02, 2017

FDA Update

U.S. Food and Drug Administration (FDA)

FDA Approves Enasidenib for Adults With Relapsed or Refractory AML With an IDH2 Mutation

August 01, 2017

Ethan Basch

Patient reported outcomes (PROs)

What Does the Evidence Show About Patient-Reported Outcomes, Quality of Life, and Survival?

August 01, 2017

Nurse empowerment

ONS Members Recognized in International Nurse Researcher Hall of Fame

August 01, 2017

improving oncology care through patient reported outcomes

Patient reported outcomes (PROs)

Improving Cancer Care Through Patient-Reported Outcomes

August 01, 2017

FDA Update

U.S. Food and Drug Administration (FDA)

FDA Grants Nivolumab Accelerated Approval for Colorectal Cancer

management of VTE in cancer patients

Advanced practice nursing (APN)

Managing VTE in Patients With Cancer

management of immunotherapy for better quality of life

Clinical practice

Management of Immunotherapy-Related Endocrinopathies

oncology patient safety in treatments

Using Standards Balances Technology Advancements With Critical Thinking

Chemotherapy administration safeety

Who Is Monitoring Your Infusions for Administration Safety?

Immunotherapy Communication

Patient-Provider Communication on Immunotherapy Can Be Improved

Immunotherapy Inquiry

The Case of the Immunotherapy Inquiry, Part II

FDA Update

U.S. Food and Drug Administration (FDA)

FDA Approves Neratinib for Extended Adjuvant Treatment of Early-Stage HER2-Positive Breast Cancer

Susan Schneider

Through Early Detection, We Can Impact Cancer Mortality

Massage therapy

Patient quality of life

Massage Has Therapeutic Value for Patients With Cancer

Cancer Immunotherapy

ONS Answers Your Top Questions About Cancer Immunotherapy

FDA Update

U.S. Food and Drug Administration (FDA)

FDA Grants Regular Approval to Blinatumomab and Expands Indication to Include Philadelphia Chromosome-Positive B Cell ALL

Palliative Care Consultation

Palliative care

Up-Front Palliative Care Consultation Associated With Better Outcomes in Advanced Cancer

USP <800>

What Oncology Nurses Need to Know About USP <800>

FDA Update

U.S. Food and Drug Administration (FDA)

FDA Approves L-Glutamine Powder for the Treatment of Sickle Cell Disease

FDA Update

U.S. Food and Drug Administration (FDA)

FDA Approves First Single NGS Test to Detect Multiple RAS Mutations

Nutritional and Physical Activity Guidelines

American Cancer Society (ACS)

Adherence to Nutritional and Physical Activity Guidelines Improves Survival in Patients With Colon Cancer

Oncology and ICU Nurses Working Together

Interdisciplinary teams

How Can Oncology and ICU Nurses Work Together to Treat Critically Ill Patients With Cancer?

Critical Care for Patients With Cancer

Clinical practice

Critical Care for Patients With Cancer

Prostate Cancer Risk

Cancer research

Less Sleep May Increase Risk of Death From Prostate Cancer

Safe handling immunotherapy

What Safe Handling and Administration Requirements Apply to Immunotherapy?

NCI Is Training the Future Cancer Research Workforce

National Cancer Institute (NCI)

How NCI Is Training the Future Cancer Research Workforce

FDA Update

U.S. Food and Drug Administration (FDA)

FDA Approves Betrixaban for Extended Duration Prophylaxis of Venous Thromboembolism

Back to Top ▲